Pfizer decided to abort the clinical trial of its daily weight loss pill 'Danuglipron' after one patient in a trial showed signs of liver damage, likely to be caused by the drug.

A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers should prioritize addressing nutrition, exercise and psychological needs.

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and cardiovascular health has significant implications for orthopedic surgery.GLP-1 ...

Some people have reported they find standing or walking painful while on the medication and even that their shoe size has changed ...

GLP-1 agonists are a true black-swan event.

Nestle SA is launching GLP-1-friendly beverages under its Boost brand that contain a proprietary whey protein microgel technology, according to the company. Nestle said the innovation allows for more ...

The study, conducted 4,489 of US adults (including 332 currently taking a GLP-1 and 151 no longer on the medication) found that most individuals taking GLP-1s for weight loss do not expect to stay on ...

Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some misconceptions about these medications and metabolic health. Centre Spring MD founder ...

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are tirzepatide (Zepbound) and semaglutide (Wegovy). Semaglutide was originally ...

Accessory company Fossil Group, which selected Assembly as its global integrated media agency in May 2024, saw an 8% increase in consumer desirability and 6% lift in purchase intent following a ...